Ternalys Therapeutics, Inc.

Biotechnology company · Chapel Hill, North Carolina, United States

Ternalys Therapeutics, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $275,766 in total, most recently in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Ternalys Therapeutics at a glance

Typebiotechnology company

HeadquartersChapel Hill, North Carolina, United States

Employees (self-reported, 2022)1

What does Ternalys Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $275,766 in total (2022). NIH funding came from the National Cancer Institute.

Frequently asked questions about Ternalys Therapeutics

Where is Ternalys Therapeutics headquartered?

Ternalys Therapeutics, Inc. is headquartered in Chapel Hill, North Carolina, United States.

What does Ternalys Therapeutics do?

Ternalys Therapeutics, Inc. is a biotechnology company.

Similar companies

BioKier, Inc.Chapel Hill, North Carolina, United States
Redbud Labs, Inc.Chapel Hill, North Carolina, United States
Clinical Tools, IncChapel Hill, North Carolina, United States
OncoTrap, Inc.Chapel Hill, North Carolina, United States
Areteia Therapeutics, Inc.Chapel Hill, North Carolina, United States
Vascular Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
Falcon Therapeutics, Inc.Chapel Hill, North Carolina, United States
Chaperone Therapeutics, Inc.Chapel Hill, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences